For the treatment of the following diseases where reduction of gastric acid is indicated: 1) Duodenal ulcer 2) Benign gastric ulcer 3) Prevention of duodenal or benign gastric ulcer recurrence 4) Gastric oesophageal reflux disease (including erosions, ulcerations and associated heartburn) 5) Gastric and/or duodenal ulcer associated with concomitant use of non-steroidal anti-inflammatory drugs